BEVACIZUMAB AND PLATINUM-BASED CHEMOTHERAPY IN RELAPSED OVARIAN CANCER TREATMENT

被引：0
|
作者：
Davidenko, I. [1 ]
Kazantseva, M. [1 ]
Porhanova, N. [1 ]
Potemin, S. [1 ]
Oganyan, M. [1 ]
Syrota, L. [1 ]
Shmatkova, V. [1 ]
机构：
[1] Reg Oncol Ctr, Krasnodar, Russia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II OVARIO Study of niraparib plus bevacizumab therapy in advanced ovarian cancer following front-line platinum-based chemotherapy with bevacizumab
    Hardesty, Melissa
    Krivak, Thomas
    Wright, Gail
    Hamilton, Erika
    Fleming, Evelyn
    Belotte, Jimmy
    Keeton, Erika
    Chen, Jian
    Clements, Aine
    Gray, Heidi
    Konecny, Gottfried
    Moore, Richard
    Richardson, Debra
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S17 - S17
  • [32] Gold as a Possible Alternative to Platinum-Based Chemotherapy for Colon Cancer Treatment
    Marmol, Ines
    Quero, Javier
    Jesus Rodriguez-Yoldi, Maria
    Cerrada, Elena
    CANCERS, 2019, 11 (06)
  • [33] Outcomes based on treatment regimen in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer receiving intravenous or intraperitoneal platinum-based chemotherapy in combination with veliparib and bevacizumab
    Washington, C. R.
    Miller, A.
    Moore, K. N.
    Bell-McGuinn, K. M.
    Schilder, R.
    Walker, J. L.
    Brady, W. E.
    O'Cearbhaill, R. E.
    Guntupalli, S. R.
    Armstrong, D. K.
    Hagemann, A. R.
    Gray, H. J.
    Duska, L. R.
    Mathews, C. A.
    Chen, A.
    O'Malley, D. M.
    Gordon, S. W.
    Aghajanian, C.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 16 - 16
  • [34] Bevacizumab Plus Platinum-Based Chemotherapy In Advanced Non-Small Cell Lung Cancer
    Wagstaff, Antona J.
    Keam, Susan J.
    McCormack, Paul L.
    BIODRUGS, 2009, 23 (03) : 187 - 196
  • [35] Pembrolizumab after platinum-based chemotherapy for treatment of metastatic bladder cancer
    Richters, A.
    Van der Heijden, A. G.
    Mehra, N.
    Meijer, R. P.
    Kiemeney, L. A.
    Boormans, J. L.
    Aben, K.
    EUROPEAN UROLOGY, 2024, 85 : S1728 - S1728
  • [36] Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer
    Della Pepa, Chiara
    Banerjee, Susana
    ONCOTARGETS AND THERAPY, 2014, 7 : 1025 - 1032
  • [37] PLATINUM-BASED CHEMOTHERAPY FOR BLADDER-CANCER
    WAXMAN, J
    WASAN, H
    SEMINARS IN ONCOLOGY, 1994, 21 (05) : 54 - 60
  • [38] OVARIO, A Phase 2 Study of Niraparib plus Bevacizumab in Advanced Ovarian Cancer Following Front-Line Platinum-Based Chemotherapy with Bevacizumab: Updated Analysis
    Hardesty, Melissa
    Krivak, Thomas
    Wright, Gail
    Hamilton, Erika
    Fleming, Evelyn
    Belotte, Jimmy
    Keeton, Erika
    Wang, Ping
    Clements, Aine
    Gray, Heidi
    Konecny, Gottfried
    Moore, Richard
    Richardson, Debra
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S27 - S28
  • [39] Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial (vol 361, pg 2099, 2003)
    Ledermann, JA
    Colombo, N
    du Bois, A
    Torri, V
    Floriani, I
    Qian, W
    Adams, HP
    Parmar, MKB
    Collins, S
    Wheeler, S
    Poli, D
    Santillo, M
    Buda, A
    Elser, G
    Schantl, P
    LANCET, 2003, 362 (9394): : 1504 - 1504
  • [40] FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy
    Ison, Gwynn
    Howie, Lynn J.
    Amiri-Kordestani, Laleh
    Zhang, Lijun
    Tang, Shenghui
    Sridhara, Rajeshwari
    Pierre, Vadryn
    Charlab, Rosane
    Ramamoorthy, Anuradha
    Song, Pengfei
    Li, Fang
    Yu, Jingyu
    Manheng, Wimolnut
    Palmby, Todd R.
    Ghosh, Soma
    Horne, Hisani N.
    Lee, Eunice Y.
    Philip, Reena
    Dave, Kaushalkumar
    Chen, Xiao Hong
    Kelly, Sharon L.
    Janoria, Kumar G.
    Banerjee, Anamitro
    Eradiri, Okponanabofa
    Dinin, Jeannette
    Goldberg, Kirsten B.
    Pierce, William F.
    Ibrahim, Amna
    Kluetz, Paul G.
    Blumenthal, Gideon M.
    Beaver, Julia A.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2018, 24 (17) : 4066 - 4071
12345